Fed. Circ. Says Thermo Fisher Can't Call Dibs On Injector IP
Key claims of a Dionex sample injector patent application are indefinite, meaning the Thermo Fisher Scientific unit doesn't have standing to fight competitor Agilent Technologies over who invented the technology first,...To view the full article, register now.
Already a subscriber? Click here to view full article